Publication | Closed Access

Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study

Hematological MalignancyLymphoid NeoplasiaTransplantationMarrow TransplantationLisocabtagene MaraleucelMedicineHematologySecond-line TherapyPharmacotherapyRadiation OncologyOncologyCell TransplantationHealth Sciences